In this study, a total of 108 participants were enrolled, with 60 categorized into the faster progression subgroup based on both the SOD1 mutation type and the estimated slope of Revised ALS Functional Rating Scale (ALSFRS‐R). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.